Electrochemical Behavior of Three-Dimensional Cobalt Manganate with Flowerlike Structures for Effective Roxarsone Sensing.

Rational design and construction of the finest electrocatalytic materials are important for improving the performance of electrochemical sensors. Spinel bioxides based on cobalt manganate (CoMn2O4) are of particular importance for electrochemical sensors due to their excellent catalytic performance. In this study, three-dimensional CoMn2O4 with the petal-free, flowerlike structure is synthesized by facile hydrothermal and calcination methods for the electrochemical sensing of roxarsone (RXS). The effect of calcination temperature on the characteristics of CoMn2O4 was thoroughly studied by in-depth electron microscopic, spectroscopic, and analytical methods. Compared to previous reports, CoMn2O4-modified screen-printed carbon electrodes display superior performance for the RXS detection, including a wide linear range (0.01-0.84 µM; 0.84-1130 µM), a low limit of detection (0.002 µM), and a high sensitivity (33.13 µA µM-1 cm-2). The remarkable electrocatalytic performance can be attributed to its excellent physical properties, such as good conductivity, hybrid architectures, high specific surface area, and rapid electron transportation. More significantly, the proposed electrochemical sensor presents excellent selectivity, good stability, and high reproducibility. Besides, the detection of RXS in river water samples using the CoMn2O4-based electrochemical sensor shows satisfactory recovery values in the range of 98.00-99.80%. This work opens a new strategy to design an electrocatalyst with the hybrid architecture for high-performance electrochemical sensing.

Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea.

The use of clozapine, an effective antipsychotic drug used in treatment-resistant schizophrenia, is associated with adverse effects. Sialorrhea is one such effect, which can be distressing for many patients. Studies on the pharmacogenetics of the adverse effects of clozapine are limited. The aim of the present study was to determine whether clozapine-induced sialorrhea is associated with a 120 base-pairs (bp) tandem duplication polymorphism in the dopamine receptor subtype D4 (DRD4) gene. Ninety-five patients, mean age 35.43±9.43 years, with treatment-resistant schizophrenia and on clozapine were included in the study. Development of sialorrhea in response to the drug, as manifested by drooling of saliva, was documented in 45 (47.4%) patients. Genotyping of the patients was carried out to detect the presence of the polymorphism of interest. Clozapine-induced sialorrhea was found to be associated significantly with the 120-bp duplication in DRD4. The association was found to fit a log-additive model with an odds ratio of 2.95 (95% confidence interval 1.51-5.75; P=0.0006). Thus, the presence of the 120-bp duplication in DRD4 appears to confer a risk for sialorrhea in response to clozapine therapy. The underlying pathophysiology and clinical significance of this phenomenon warrant further investigation.